The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Prostate Specific Antigen (PSA) Biomarker Market Research Report 2025
Synopsis
Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland. The PSA test measures the level of PSA in a man's blood. For this test, a blood sample is sent to a laboratory for analysis.
The global Prostate Specific Antigen (PSA) Biomarker market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Prostate Specific Antigen (PSA) Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Prostate Specific Antigen (PSA) Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Prostate Specific Antigen (PSA) Biomarker in Diagnostics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Prostate Specific Antigen (PSA) Biomarker include Abbott, Siemens Healthcare, DiaSorin, Roche, Tosoh Bioscience, Fujirebio, BodiTech, GE Healthcare and Endocare, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Prostate Specific Antigen (PSA) Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Specific Antigen (PSA) Biomarker.
Report Scope
The Prostate Specific Antigen (PSA) Biomarker market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prostate Specific Antigen (PSA) Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostate Specific Antigen (PSA) Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Siemens Healthcare
DiaSorin
Roche
Tosoh Bioscience
Fujirebio
BodiTech
GE Healthcare
Endocare
Quest Diagnostics
Bio-Rad Laboratories
QIAGEN
Myriad RBM
Segment by Type
Blood
Semen
Urine
Segment by Application
Diagnostics
Drug Discovery
Personalized Medicine
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Specific Antigen (PSA) Biomarker companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland. The PSA test measures the level of PSA in a man's blood. For this test, a blood sample is sent to a laboratory for analysis.
The global Prostate Specific Antigen (PSA) Biomarker market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Prostate Specific Antigen (PSA) Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Prostate Specific Antigen (PSA) Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Prostate Specific Antigen (PSA) Biomarker in Diagnostics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Prostate Specific Antigen (PSA) Biomarker include Abbott, Siemens Healthcare, DiaSorin, Roche, Tosoh Bioscience, Fujirebio, BodiTech, GE Healthcare and Endocare, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Prostate Specific Antigen (PSA) Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Specific Antigen (PSA) Biomarker.
Report Scope
The Prostate Specific Antigen (PSA) Biomarker market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prostate Specific Antigen (PSA) Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostate Specific Antigen (PSA) Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Siemens Healthcare
DiaSorin
Roche
Tosoh Bioscience
Fujirebio
BodiTech
GE Healthcare
Endocare
Quest Diagnostics
Bio-Rad Laboratories
QIAGEN
Myriad RBM
Segment by Type
Blood
Semen
Urine
Segment by Application
Diagnostics
Drug Discovery
Personalized Medicine
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Specific Antigen (PSA) Biomarker companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Specific Antigen (PSA) Biomarker Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Blood
1.2.3 Semen
1.2.4 Urine
1.3 Market by Application
1.3.1 Global Prostate Specific Antigen (PSA) Biomarker Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Personalized Medicine
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate Specific Antigen (PSA) Biomarker Market Perspective (2019-2030)
2.2 Prostate Specific Antigen (PSA) Biomarker Growth Trends by Region
2.2.1 Global Prostate Specific Antigen (PSA) Biomarker Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Prostate Specific Antigen (PSA) Biomarker Historic Market Size by Region (2019-2024)
2.2.3 Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Region (2025-2030)
2.3 Prostate Specific Antigen (PSA) Biomarker Market Dynamics
2.3.1 Prostate Specific Antigen (PSA) Biomarker Industry Trends
2.3.2 Prostate Specific Antigen (PSA) Biomarker Market Drivers
2.3.3 Prostate Specific Antigen (PSA) Biomarker Market Challenges
2.3.4 Prostate Specific Antigen (PSA) Biomarker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Specific Antigen (PSA) Biomarker Players by Revenue
3.1.1 Global Top Prostate Specific Antigen (PSA) Biomarker Players by Revenue (2019-2024)
3.1.2 Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Players (2019-2024)
3.2 Global Prostate Specific Antigen (PSA) Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate Specific Antigen (PSA) Biomarker Revenue
3.4 Global Prostate Specific Antigen (PSA) Biomarker Market Concentration Ratio
3.4.1 Global Prostate Specific Antigen (PSA) Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Specific Antigen (PSA) Biomarker Revenue in 2023
3.5 Prostate Specific Antigen (PSA) Biomarker Key Players Head office and Area Served
3.6 Key Players Prostate Specific Antigen (PSA) Biomarker Product Solution and Service
3.7 Date of Enter into Prostate Specific Antigen (PSA) Biomarker Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Specific Antigen (PSA) Biomarker Breakdown Data by Type
4.1 Global Prostate Specific Antigen (PSA) Biomarker Historic Market Size by Type (2019-2024)
4.2 Global Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Type (2025-2030)
5 Prostate Specific Antigen (PSA) Biomarker Breakdown Data by Application
5.1 Global Prostate Specific Antigen (PSA) Biomarker Historic Market Size by Application (2019-2024)
5.2 Global Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Prostate Specific Antigen (PSA) Biomarker Market Size (2019-2030)
6.2 North America Prostate Specific Antigen (PSA) Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2019-2024)
6.4 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prostate Specific Antigen (PSA) Biomarker Market Size (2019-2030)
7.2 Europe Prostate Specific Antigen (PSA) Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2019-2024)
7.4 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size (2019-2030)
8.2 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Region (2019-2024)
8.4 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size (2019-2030)
9.2 Latin America Prostate Specific Antigen (PSA) Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2019-2024)
9.4 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size (2019-2030)
10.2 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2019-2024)
10.4 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Prostate Specific Antigen (PSA) Biomarker Introduction
11.1.4 Abbott Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 Siemens Healthcare
11.2.1 Siemens Healthcare Company Detail
11.2.2 Siemens Healthcare Business Overview
11.2.3 Siemens Healthcare Prostate Specific Antigen (PSA) Biomarker Introduction
11.2.4 Siemens Healthcare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.2.5 Siemens Healthcare Recent Development
11.3 DiaSorin
11.3.1 DiaSorin Company Detail
11.3.2 DiaSorin Business Overview
11.3.3 DiaSorin Prostate Specific Antigen (PSA) Biomarker Introduction
11.3.4 DiaSorin Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.3.5 DiaSorin Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Prostate Specific Antigen (PSA) Biomarker Introduction
11.4.4 Roche Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.4.5 Roche Recent Development
11.5 Tosoh Bioscience
11.5.1 Tosoh Bioscience Company Detail
11.5.2 Tosoh Bioscience Business Overview
11.5.3 Tosoh Bioscience Prostate Specific Antigen (PSA) Biomarker Introduction
11.5.4 Tosoh Bioscience Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.5.5 Tosoh Bioscience Recent Development
11.6 Fujirebio
11.6.1 Fujirebio Company Detail
11.6.2 Fujirebio Business Overview
11.6.3 Fujirebio Prostate Specific Antigen (PSA) Biomarker Introduction
11.6.4 Fujirebio Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.6.5 Fujirebio Recent Development
11.7 BodiTech
11.7.1 BodiTech Company Detail
11.7.2 BodiTech Business Overview
11.7.3 BodiTech Prostate Specific Antigen (PSA) Biomarker Introduction
11.7.4 BodiTech Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.7.5 BodiTech Recent Development
11.8 GE Healthcare
11.8.1 GE Healthcare Company Detail
11.8.2 GE Healthcare Business Overview
11.8.3 GE Healthcare Prostate Specific Antigen (PSA) Biomarker Introduction
11.8.4 GE Healthcare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.8.5 GE Healthcare Recent Development
11.9 Endocare
11.9.1 Endocare Company Detail
11.9.2 Endocare Business Overview
11.9.3 Endocare Prostate Specific Antigen (PSA) Biomarker Introduction
11.9.4 Endocare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.9.5 Endocare Recent Development
11.10 Quest Diagnostics
11.10.1 Quest Diagnostics Company Detail
11.10.2 Quest Diagnostics Business Overview
11.10.3 Quest Diagnostics Prostate Specific Antigen (PSA) Biomarker Introduction
11.10.4 Quest Diagnostics Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.10.5 Quest Diagnostics Recent Development
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Company Detail
11.11.2 Bio-Rad Laboratories Business Overview
11.11.3 Bio-Rad Laboratories Prostate Specific Antigen (PSA) Biomarker Introduction
11.11.4 Bio-Rad Laboratories Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.11.5 Bio-Rad Laboratories Recent Development
11.12 QIAGEN
11.12.1 QIAGEN Company Detail
11.12.2 QIAGEN Business Overview
11.12.3 QIAGEN Prostate Specific Antigen (PSA) Biomarker Introduction
11.12.4 QIAGEN Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.12.5 QIAGEN Recent Development
11.13 Myriad RBM
11.13.1 Myriad RBM Company Detail
11.13.2 Myriad RBM Business Overview
11.13.3 Myriad RBM Prostate Specific Antigen (PSA) Biomarker Introduction
11.13.4 Myriad RBM Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.13.5 Myriad RBM Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
